UCSF Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- N/A at this time
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: Dec 19, 2025
UC Noyce Initiative RFP for Computational Health Applications
Given that diseases do not exist on a single scale, to make real progress in preventing and treating complex diseases, we need science that integrates data across levels; from the molecular to the systemic, from the individual to the population. To address this need, the UC Noyce Initiative will invest in collaborative, computationally driven research to decode disease across scales to support multi-scale integration and system-level discovery. - Extended Deadline: Jan 9, 2026
Computational Cancer Research RFA
The Center for Cancer Data Science, a partnership between The Helen Diller Family Comprehensive Cancer Center and the Bakar Computational Health Sciences Institute, is requesting applications for projects in computational cancer research that harness data available in Information Commons/Cancer Commons.
Foundations/Other Sources
- Deadlines: Various dates through Feb 3, 2026
Children's Tumor Foundation Discovery Fund Grants
The Children’s Tumor Foundation has issued three RFAs in the field of neurofibromatosis (NF) and related disorders, including schwannomatosis: (1) Young Investigator Award; (2) Drug Discovery Initiative; (3) Clinical Research Award. - Deadline: Dec 15, 2025
The Elsa U. Pardee Foundation Supporting Innovative Cancer Research
The Elsa U. Pardee Foundation has issued a request for applications for cancer research grants. Proposed projects may be relevant to any area of cancer detection, treatment, or cure. Funding is intended to allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers, and lead to subsequent and expanded support using government agency funding. - Deadline: Dec 18, 2025
Breast Cancer Research Foundation-AACR NextGen Grant for Transformative Cancer Research
This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence. The proposed project may be basic, translational, clinical, or population-based research in nature and must have direct applicability and relevance to breast cancer. - LOI Deadline: Jan 6, 2026
PCORI Award: Partnering Research and Community Organizations for Comparative Clinical Effectiveness Research Across the Cancer Care Continuum
Seeking to fund high-impact, patient-centered comparative clinical effectiveness research (CER) projects led by researcher and community partnerships to focus on advancing care and outcomes across different phases of the cancer care continuum. - Deadline: Jan 9, 2026
NCCN Lung Cancer Screening Quality Improvement Initiative
National Comprehensive Cancer Network (NCCN) in collaboration with Merck Sharp & Dohme Corporation are offering a new funding opportunity in the area of lung cancer screening. Investigators are invited to develop and submit proposals outlining quality improvement and implementation science projects focused on improving the uptake of, and adherence to, lung cancer screening in people at high risk. - Deadline: Jan 9, 2026
Cancer Research Institute IGNITE Award
The Cancer Research Institute (CRI) has issued a request for applications for its IGNITE Award (Inspiring Growth and Nurturing Independence Through Excellence) program. This program supports the transition of outstanding postdoctoral researchers into independent tenure-track cancer investigators. - Extended Deadline: Jan 13, 2026
NCCN Decision Making, Quality of Life, and Outcome Improvement Initiatives in Chronic Myeloid Leukemia (CML)
NCCN, in collaboration with Novartis, is pleased to continue to invite investigators at NCCN Member Institutions to submit proposals for innovative Chronic Myeloid Leukemia (CML) initiatives focused on improving decision making, quality of life, and clinical outcomes. - Deadline: Jan 15, 2026
AACR/Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant
his award will support a multi-institutional team with Principal Investigators from at least one institution in the United States and one in Asia. The focus is on collaborative research in gastric or esophageal cancer, specifically in areas such as resistance, metastasis, innovative treatment strategies (including identifying and characterizing novel targets), and cellular and immunotherapies. Proposals must include plans indicating how the work will be translated into the clinic, including an estimated timeline. - Deadline: Jan 23, 2026
Mount Zion Health Fund RFP
This RFP is a special call for proposals for initiatives that advance health equity, patient well-being, and academic-community collaboration in alignment with MZHF’s restricted fund purposes. Mount Zion Health Fund reflects the Jewish values and legacy of Mount Zion Hospital by supporting programs and research that improve the physical, emotional and spiritual health of vulnerable populations in San Francisco. - Deadline: Jan 30, 2026
California Initiative to Advance Precision Medicine (CIAPM) Grants
Supports representative precision medicine research aimed at reducing health disparities and increasing participation from historically underrepresented groups in biomedical research. Funding will support research that advances precision medicine approaches reflective of California’s diverse communities.
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
- N/A
To view NCI funding opportunities, search here
In accordance with Federal and State law and University policy, the University of California does not discriminate on the basis of age, gender, race, ethnicity, national origin, religion, sexual orientation, gender identity, health, or disability. For detailed information, please visit the Office for the Prevention of Harassment and Discrimination.